StonvexLoading…
StonvexStonvexStonvexCore line items from GEN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-03-28 | Annual 2024 2024-03-29 | Annual 2023 2023-03-31 | Annual 2022 2022-04-01 |
|---|---|---|---|---|
Revenue | $3.94B | $3.80B | $3.32B | $2.80B |
Operating Income | $1.61B | $1.11B | $1.21B | $1.00B |
Net Income | $643.00M | $607.00M | $1.33B | $836.00M |
EPS (Diluted) | $1.03 | $0.95 | $2.14 | $1.41 |
Total Assets | $15.49B | $15.79B | $15.95B | $6.94B |
Total Liabilities | $13.23B | $13.65B | $13.75B | $7.04B |
Cash & Equivalents | $1.01B | $846.00M | $750.00M | $1.89B |
Free Cash Flow OCF − CapEx | $1.21B | $2.04B | $751.00M | $968.00M |
Shares Outstanding | 617.00M | 623.00M | 640.00M | 582.00M |